Objectives: Survey and compare effect of Olibanum and Curcumin supplementation on blood and inflammatory factors in rheumatoid arthritis patients
Design: Double blind Clinical trial
Procedure: Ninety patients with rheumatoid arthritis will be enrolled and divided randomly based on random numbers tables into three groups (Olibanum and Curcumin) and placebo. Blinding will be done for patients and researchers.
Inclusion criteria: Diagnosis of rheumatoid arthritis specialist according 1987 ACR (ACR); Lack of pregnancy and lactation
Exclusion criteria: Diseases that require special treatment and the intervention disrupts (such as accidents, trauma or exacerbation for reasons such as extreme stress); alcoholic; allergic to Olibanum and curcumin
Intervention: The first group for three months, three capsules of 500 mg per day, and to the second group, 3 capsules of curcumin 40, and to the third group (control), 3 capsules of 500 mg of placebo were given in terms of apparent characteristics, which are quite similar to the intervention material.
The main outcome variables: Blood tests including cholesterol, triglyceride, HDL, LDL, TFN-alpha and HS-CRP, antioxidant, fasting blood sugar and insulin factors before and after the intervention will be measured